Anticardiolipin antibodies and autoimmune diseases.
Anticardiolipin antibodies and autoimmune diseases.
复制标题
抗心磷脂抗体和自身免疫性疾病。
DOI:
10.1097/00002281-198901020-00015
复制
发表时间:
1989
影响因子:
5.1
通讯作者:
Harris En
中科院分区:
文献类型:
--
作者:
Harris En
Anticardiolipin antibodies are truly a subject of the 1980s.[1] Admittedly, we have known for several decades that syphilis can induce antibodies that bind cardiolipin, this binding being demonstrated best by agglutination or complement fixation tests (Catterall, in Walker, ed. Ninth Symposium on Advanced lledicine. Pitman, 1977, pp 97–111). We have also known that patients with a variety of autoimmune disorders sometimes have false-positive tests for syphilis, suggesting that anticardiolipin antibodies were one of a spectrum of non-organ-specific autoantibodies produced in these disorders (Moore and Mohr, JAMA 1952, 150.467–473) However, in 1983, with the development of a solidphase radioimmunoassay test for anticardiolipin anti-bodies (Harris et al. Lancet 1983, ii: 1211–1214), we may have stumbled on a somewhat" new" group of autoantibodies specific for cardiolipin and other anionic phospholipids (Harris et al.,/Clin Lab Immunol 1985, 17: 155–162), More importantly, it now appears that a subgroup of these antibodies are associated with an increased risk of thrombosis, recurrent fetal loss, and thrombocytopenia, particularly when antibody titers are high and of the IgG isotype (Harris et al., Arch Intern Med 1986, 1462153–2159)It is likely that anticardiolipin antibodies detected by solid-phase immunoassays are part of a family of antibodies that bind cardiolipin and other phospholipid molecules. This family of antibodies is best designated" antiphospholipid antibodies"(Harris, Clin Rheum Dis 1985, 11591–596). In addition to diseases such as systemic lupus erythematosus and syphilis, these antibodies may be induced in a variety of infectious, autoimmune, and drug-induced disorders, as well as in otherwise healthy individuals.